Inherited Cancer Syndromes101
Image For Activity Cover
Availability
On-Demand
Expires on 03/31/2025
Cost
$0.00
Credit Offered
0.5 CME (AMA) Credit
0.5 CME (Other) Credit

 

Date of Release: 3/1/2022

Expiration Date: 3/1/2025

Credits offered: 0.5 CME

Estimate time of completion: 30 minutes

Course/Module must be completed by the expiration date

 

This course is supported by an independent medical education grant from Illumina, Inc.

 

Learning Objectives:

At the conclusion of the module, participants should be able to:

  • Identify the Red flags for Inherited Cancer Predisposition
  • Describe Hereditary, Familial, and Sporadic cancers
  • Recognize the potential germline significance of somatic gene testing

 

Target Audience:

This course is primarily for the non-geneticist healthcare professional.

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Credit Designation

The American College of Medical Genetics and Genomics designates this online enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Claiming your Educational Credits

This activity consists of 10 independent modules, each with a posttest and evaluation. The test may be taken as often as necessary to achieve a passing score of 100% is required to receive credit.  If you do not achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Financial Disclosures

The following course director, program planning committee members, speakers, and staff for this activity, have no financial relationships with ineligible companies relevant to the content of this course.

 

Name

Role(s)

Relationship(s)

 

Planning Member

Faculty/ Presenter

Peer Reviewer

 

Tuya Pal, MD, FACMG

Vanderbilt University Medical Center

Vanderbilt-Ingram Cancer Center

 

 

Nothing to disclose

Fuki M. Hisama, MD, FAAN, FACMG

University of Washington School of Medicine

Nothing to disclose

Susan Klugman MD, FACMG, FACOG

Albert Einstein College of Medicine/Montefiore Medical Center

 

Nothing to disclose

Shweta Dhar, MD, MS, FACMG

(Course Director)

Baylor College of Medicine

Michael E. Debakey VA Medical Center

Nothing to disclose

Jane Radford, MHA, CHCP

ACMG Education

 

 

Nothing to disclose

 

 

 

 

 

 

 

 

 

 

Peer Review

In December of 2021, this continuing medical education online enduring activity was reviewed by Drs. Shweta Dhar and Fuki Hisama. To ensure the continued scientific relevance of this enduring material, its content will be reviewed again prior to the expiry date.

 

Disclaimer

ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and or exclusive of other procedures and that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.

 

Questions regarding CE credit should be directed to education@acmg.net

 

 

© 2022 American College of Medical Genetics and Genomics. All rights reserved.

Powered By